Micro Medical Solutions was founded with the core mission of developing innovative microvascular intervention therapies to treat peripheral artery disease (PAD). The company's vision is to significantly reduce the number of amputations caused by critical limb ischemia (CLI), a severe form of PAD. Their primary product offerings focus on advanced medical devices and procedures designed to improve blood flow in small blood vessels, thereby enhancing patient outcomes and quality of life. Micro Medical Solutions targets healthcare providers and patients affected by PAD, aiming to transform the standard of care in this specialized market.

Notable affiliated individuals include leading vascular surgeons and medical device experts who contribute to the company's research and development efforts. The company has garnered attention from prominent investors in the healthcare sector, supporting its mission to combat CLI-related amputations. Key achievements include successful clinical trials demonstrating the efficacy of their therapies and obtaining regulatory approvals for their products. Overall, Micro Medical Solutions has made a significant impact by providing innovative solutions that address a critical need in vascular health, potentially saving thousands of limbs and improving patient lives.